Citation: Lm. Kondo et al., Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia, ANN PHARMAC, 35(4), 2001, pp. 440-451
Citation: Bs. Wiggins et al., Clinical use of new antithrombotic therapies for medical management of acute coronary syndromes (vol 21, pg 324, 2001), PHARMACOTHE, 21(7), 2001, pp. 889-889
Citation: Bs. Wiggins et al., Clinical use of new antithrombotic therapies for medical management of acute coronary syndromes, PHARMACOTHE, 21(3), 2001, pp. 320-337
Authors:
Weibert, RT
Yeager, BF
Wittkowsky, AK
Bussey, HI
Wilson, DB
Godwin, JE
Adler, DS
Black, EA
McGee, DL
Vlasses, PH
Citation: Rt. Weibert et al., A randomized, crossover comparison of warfarin products in the treatment of chronic atrial fibrillation, ANN PHARMAC, 34(9), 2000, pp. 981-988
Citation: W. Wong et al., Influence of warfarin regimen type on clinical and monitoring outcomes in stable patients in an anticoagulation management service, PHARMACOTHE, 19(12), 1999, pp. 1385-1391